Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective

M Hasan Toper1, Sulen Sarioglu

  • 1Department of Molecular Pathology, Graduate School of Health Sciences, Dokuz Eylul University, Izmir, Turkey.

Insights

Recent advancements reveal key genomic alterations in salivary gland neoplasms, aiding in diagnosis and classification. These genetic changes offer insights into tumor development and potential biomarkers.

Area of Science:

  • Oncology
  • Molecular Pathology
  • Genetics

Background:

  • Salivary gland neoplasms are rare and diverse tumors.
  • Understanding their molecular basis is crucial for accurate diagnosis and treatment.
  • Current knowledge of the molecular landscape is expanding but remains incomplete.

Purpose of the Study:

  • To review recent progress in the molecular pathology of salivary gland tumors.
  • To highlight distinctive molecular characteristics and their diagnostic significance.
  • To discuss the potential of genetic aberrations as biomarkers.

Main Methods:

  • Literature review of recent studies on salivary gland tumor genetics.
  • Focus on specific chromosomal rearrangements and gene fusions.
  • Analysis of molecular alterations in various salivary gland neoplasm subtypes.

Main Results:

  • Identified key genomic aberrations in common salivary gland tumors, including CRTC1-MAML2, MYB-NFIB, PLAG1, HMGA2, ETV6 fusions, and EWSR1 fusions.
  • These genetic alterations provide insights into the molecular pathogenesis.
  • Specific genetic aberrations are valuable diagnostic tools and potential prognostic/predictive biomarkers.

Conclusions:

  • Genomic aberrations are pivotal in understanding salivary gland neoplasms.
  • Molecular profiling enhances tumor classification and diagnosis.
  • Further research into these genetic alterations may lead to improved therapeutic strategies.